PRAXBIND
PRAXBIND
Approved
DIN Number
02454343
Drug Class
Human
Market Date
May 24, 2016
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02454343
AIG Number0158090001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
V03AB37 IDARUCIZIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:28.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
IDARUCIZUMABActive
Strength: 50 MG / ML
Monograph: IDARUCIZUMAB